Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) (2010)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3892/or_00001001
- Subjects: BIOLOGIA MOLECULAR; FENÓTIPOS; ADENOCARCINOMA; HPV (EPIDEMIOLOGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncology reports
- ISSN: 1021-335X
- Volume/Número/Paginação/Ano: v. 24, n. 6, p. 1419-1426, 2012
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
RAMALHO, Alan Saito et al. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review). Oncology reports, v. 24, n. 6, p. 1419-1426, 2010Tradução . . Disponível em: https://doi.org/10.3892/or_00001001. Acesso em: 06 maio 2026. -
APA
Ramalho, A. S., Lopes, A. D., Talans, A., Sakiyama, B. Y. P., Pereira, G. L. S., Hoff, P. M., & De Castro Jr., G. (2010). Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review). Oncology reports, 24( 6), 1419-1426. doi:10.3892/or_00001001 -
NLM
Ramalho AS, Lopes AD, Talans A, Sakiyama BYP, Pereira GLS, Hoff PM, De Castro Jr. G. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) [Internet]. Oncology reports. 2010 ; 24( 6): 1419-1426.[citado 2026 maio 06 ] Available from: https://doi.org/10.3892/or_00001001 -
Vancouver
Ramalho AS, Lopes AD, Talans A, Sakiyama BYP, Pereira GLS, Hoff PM, De Castro Jr. G. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) [Internet]. Oncology reports. 2010 ; 24( 6): 1419-1426.[citado 2026 maio 06 ] Available from: https://doi.org/10.3892/or_00001001 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
